Literature DB >> 28619253

The N-Methyl-D-Aspartate Receptor: Memory, Madness, and More.

Alejandro Ramirez1, Melissa R Arbuckle2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28619253      PMCID： PMC5714278          DOI： 10.1016/j.biopsych.2017.05.007

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

Review 1.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

Review 2.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

Review 4.  Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.

Authors:  Bita Moghaddam; John H Krystal
Journal:  Schizophr Bull       Date:  2012-08-16       Impact factor: 9.306

5.  Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Authors:  Kerry J Ressler; Barbara O Rothbaum; Libby Tannenbaum; Page Anderson; Ken Graap; Elana Zimand; Larry Hodges; Michael Davis
Journal:  Arch Gen Psychiatry       Date:  2004-11

6.  Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.

Authors:  Dragana Bugarski-Kirola; Thomas Blaettler; Celso Arango; Wolfgang W Fleischhacker; George Garibaldi; Alice Wang; Mark Dixon; Rodrigo A Bressan; Henry Nasrallah; Stephen Lawrie; Julie Napieralski; Tania Ochi-Lohmann; Carol Reid; Stephen R Marder
Journal:  Biol Psychiatry       Date:  2016-12-15       Impact factor: 13.382

7.  Synaptic Plasticity: The Role of Learning and Unlearning in Addiction and Beyond.

Authors:  Alejandro Ramirez; Melissa R Arbuckle
Journal:  Biol Psychiatry       Date:  2016-09-08       Impact factor: 13.382

8.  Phencyclidine-induced psychosis.

Authors:  R M Allen; S J Young
Journal:  Am J Psychiatry       Date:  1978-09       Impact factor: 18.112

9.  Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.

Authors:  Daniel Umbricht; Daniela Alberati; Meret Martin-Facklam; Edilio Borroni; Eriene A Youssef; Michael Ostland; Tanya L Wallace; Frédéric Knoflach; Ernest Dorflinger; Joseph G Wettstein; Alexander Bausch; George Garibaldi; Luca Santarelli
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596
  9 in total
  2 in total

1.  NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.

Authors:  Lin Xu; Xiaofei Qiu; Shuo Wang; Qingshan Wang; Xiu-Lan Zhao
Journal:  Neurosci Bull       Date:  2018-12-19       Impact factor: 5.203

Review 2.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.